Tech Company Financing Transactions
Lifecode Funding Round
Lifecode closed a $20.5 million Series A venture capital round on 2/20/2015. Investors included Mayo Medical Ventures, Sequoia Capital and private investors.
Transaction Overview
Company Name
Announced On
2/20/2015
Transaction Type
Venture Equity
Amount
$20,500,000
Round
Series A
Investors
Mayo Medical Ventures (Lead Investor)
Sequoia Capital (Lead Investor)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
348 Hatch Dr.
Foster City, CA 94404
USA
Foster City, CA 94404
USA
Phone
Website
Email Address
Not Recorded
Overview
Lifecode is a specialized CLIA and CAP certified clinical laboratory focused on the genetic basis of human disease. With an initial focus on oncology, we are committed to improving the lives of patients through molecular information that is concise, accurate and actionable.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Chris Rivest
Chief Scientific Officer
Dietrich Stephan
Chief Technical Officer
Sivan Bercovici
VP - R & D
Eugene Fratkin
VP - Regulatory Affairs
Donna Hongo
Browse more venture capital transactions:
Prev: 2/20/2015: Revmetrix venture capital transaction
Next: 2/20/2015: NVoicePay venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs